TUCAXEN 150 Tucatinib150 Mg

Tucaxen 150 (Tucatinib) Tablets is a targeted oncology medicine containing Tucatinib INN 150 mg, a selective HER2 tyrosine kinase inhibitor that blocks HER2 signaling pathways responsible for cancer cell growth. It is primarily used in the treatment of HER2-positive breast cancer, including advanced or metastatic cases, as prescribed by an oncologist. Each pack contains 30 film-coated tablets for oral administration. Manufactured by Everest Pharmaceuticals Ltd., this product complies with international quality standards and is suitable for oncology hospitals, pharmaceutical distributors, and exporters.